150 related articles for article (PubMed ID: 27385106)
1. Proteome analysis of adrenal cortical tumors.
Kim HM; Lee YK; Koo JS
Expert Rev Proteomics; 2016 Aug; 13(8):747-55. PubMed ID: 27385106
[TBL] [Abstract][Full Text] [Related]
2. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA Expression Profiling in Adrenal Myelolipoma.
Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
[TBL] [Abstract][Full Text] [Related]
4. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
[TBL] [Abstract][Full Text] [Related]
5. Sum of High-Risk Gene Mutation (SHGM): A Novel Attempt to Assist Differential Diagnosis for Adrenocortical Carcinoma with Benign Adenoma, Based on Detection of Mutations of Nine Target Genes.
Zheng GY; Zhang XB; Li HZ; Zhang YS; Deng JH; Wu XC
Biochem Genet; 2021 Aug; 59(4):902-918. PubMed ID: 33564960
[TBL] [Abstract][Full Text] [Related]
6. Weiss criteria in large adrenocortical tumors: a validation study.
Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
[TBL] [Abstract][Full Text] [Related]
7. A Diagnostic Approach to Adrenocortical Tumors.
Hodgson A; Pakbaz S; Mete O
Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma.
Duan K; Gucer H; Kefeli M; Asa SL; Winer DA; Mete O
Endocr Pathol; 2020 Sep; 31(3):231-238. PubMed ID: 32367334
[TBL] [Abstract][Full Text] [Related]
9. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
10. Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status.
Zhang J; Wang C; Gao J; Sun J; Zeng X; Wu S; Liang Z
Diagn Pathol; 2014 Jan; 9():19. PubMed ID: 24457059
[TBL] [Abstract][Full Text] [Related]
11. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
[TBL] [Abstract][Full Text] [Related]
12. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of adrenocortical cancer.
Lehmann T; Wrzesinski T
Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA Expression in Adrenal Cortical Neoplasms.
Shiyanbola O; Hardin H; Hu R; Eickhoff JC; Lloyd RV
Endocr Pathol; 2020 Dec; 31(4):385-391. PubMed ID: 32725507
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of the
Scicluna P; Caramuta S; Kjellin H; Xu C; Fröbom R; Akhtar M; Gao J; Shi H; Kjellman M; Almgren M; Höög A; Zedenius J; Ekström TJ; Bränström R; Lui WO; Larsson C
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36169175
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
Giordano TJ
Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
[TBL] [Abstract][Full Text] [Related]
17. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas.
Sarkaria IS; Stojadinovic A; Talbot SG; Hoos A; Dudas ME; Brennan MF; Ghossein RA; Singh B
Surgery; 2004 Dec; 136(6):1122-8. PubMed ID: 15657565
[TBL] [Abstract][Full Text] [Related]
19. Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management.
Ahmed AA; Thomas AJ; Ganeshan DM; Blair KJ; Lall C; Lee JT; Morshid AI; Habra MA; Elsayes KM
Abdom Radiol (NY); 2020 Apr; 45(4):945-963. PubMed ID: 31894378
[TBL] [Abstract][Full Text] [Related]
20. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
